1. Home
  2. FORD vs NLSP Comparison

FORD vs NLSP Comparison

Compare FORD & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORD
  • NLSP
  • Stock Information
  • Founded
  • FORD 1961
  • NLSP 2015
  • Country
  • FORD United States
  • NLSP Switzerland
  • Employees
  • FORD N/A
  • NLSP N/A
  • Industry
  • FORD Plastic Products
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORD Industrials
  • NLSP Health Care
  • Exchange
  • FORD Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • FORD 4.7M
  • NLSP 5.2M
  • IPO Year
  • FORD 1995
  • NLSP 2021
  • Fundamental
  • Price
  • FORD $4.52
  • NLSP $2.00
  • Analyst Decision
  • FORD
  • NLSP
  • Analyst Count
  • FORD 0
  • NLSP 0
  • Target Price
  • FORD N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • FORD 17.7K
  • NLSP 450.1K
  • Earning Date
  • FORD 02-12-2025
  • NLSP 12-31-2024
  • Dividend Yield
  • FORD N/A
  • NLSP N/A
  • EPS Growth
  • FORD N/A
  • NLSP N/A
  • EPS
  • FORD N/A
  • NLSP N/A
  • Revenue
  • FORD $31,358,448.00
  • NLSP N/A
  • Revenue This Year
  • FORD N/A
  • NLSP N/A
  • Revenue Next Year
  • FORD N/A
  • NLSP N/A
  • P/E Ratio
  • FORD N/A
  • NLSP N/A
  • Revenue Growth
  • FORD N/A
  • NLSP N/A
  • 52 Week Low
  • FORD $3.10
  • NLSP $1.73
  • 52 Week High
  • FORD $8.29
  • NLSP $24.32
  • Technical
  • Relative Strength Index (RSI)
  • FORD 64.51
  • NLSP 22.65
  • Support Level
  • FORD $4.35
  • NLSP $1.75
  • Resistance Level
  • FORD $5.00
  • NLSP $2.13
  • Average True Range (ATR)
  • FORD 0.23
  • NLSP 0.29
  • MACD
  • FORD 0.02
  • NLSP -0.03
  • Stochastic Oscillator
  • FORD 58.26
  • NLSP 4.23

About FORD Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. It designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as smartphones, tablets, personal computers, notebooks, and global Positioning System devices. It operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the US.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: